The Life of Aducanumab: A Potential Novel Alzheimer’s Disease Drug

On October 22nd, 2019, headlines read “Biogen plans regulatory filing for Aducanumab for Alzheimer’s disease based on new analysis of larger dataset from phase 3 studies”. Alzheimer’s disease (AD) is a devastating neurodegenerative disease characterized by cognitive dysfunction and memory loss. It is the 6th leading cause of adult deaths in the United States. Biogen … Continue reading The Life of Aducanumab: A Potential Novel Alzheimer’s Disease Drug

What is 6 Weeks Worth? The Cost of Cancer Drugs and Extending Life

By: Sadie Steffens, 4th year PhD candidate in the Biomedical Sciences Graduate Program You’d be hard-pressed to find anyone who hasn’t been affected by cancer in some way. Second only to heart disease as the leading cause of death, many of us have friends or loved ones who have suffered from cancer. News reports with big claims … Continue reading What is 6 Weeks Worth? The Cost of Cancer Drugs and Extending Life